A case of renal salt-wasting syndrome induced by cisplatin and 5-FU during treatment of esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

A case of renal salt-wasting syndrome induced by cisplatin and 5-FU during treatment of esophageal squamous cell carcinoma

Published:2019-07-30 Issue:2 Volume:27 Page:64-66
ISSN:1344-6835
Container-title:Annals of Cancer Research and Therapy
language:en
Short-container-title:Ann. Cancer Res. Therap.

Author:

Shimizu Dai¹,Kanda Mitsuro¹,Koike Masahiko¹,Umeda Shinichi¹,Sonohara Fuminori¹,Takami Hideki¹,Inokawa Yoshikuni¹,Hattori Norifumi¹,Hayashi Masamichi¹,Tanaka Chie¹,Kobayashi Daisuke¹,Yamada Suguru¹,Nakayama Goro¹,Fujiwara Michitaka¹,Kodera Yasuhiro¹

Affiliation:

1. Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine

Publisher

The Japanese Society of Strategies for Cancer Research and Therapy

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://www.jstage.jst.go.jp/article/acrt/27/2/27_64/_pdf

Reference17 articles.

1. 1) Arany I and Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23: 460–464. DOI: 10.1016/S0270-9295(03)00089-5

2. 2) Berghmans T (1996) Hyponatremia related to medical anticancer treatment. Support Care Cancer 4: 341–350. DOI: 10.1007/BF01788840

3. 3) Henry DA (2015) In The Clinic: Hyponatremia. Ann Intern Med 163: Itc1-19.

4. 4) Ball S (2000) Hyponatremia. In: Endotext (Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP eds.). South Dartmouth (MA): MDText.com, Inc.

5. 5) Kurtzberg J, Dennis VW, and Kinney TR (1984) Cisplatinum-induced renal salt wasting. Med Pediatr Oncol 12: 150–154. DOI: 10.1002/mpo.2950120219